Original
Tratamiento con 177LU-DOTATATE en tumores neuroendocrinos. Estudio preliminar
177Lu-DOTATATE treatment in neuroendocrine tumours. A preliminary study
Leído
462
Vecesse ha leído el artículo
150
Total PDF
312
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 8 | 1 | 2 | 3 |
| 2024 5 | 2 | 2 | 4 |
| 2024 4 | 18 | 0 | 18 |
| 2024 2 | 5 | 1 | 6 |
| 2023 10 | 10 | 1 | 11 |
| 2023 5 | 4 | 1 | 5 |
| 2023 4 | 1 | 0 | 1 |
| 2023 3 | 14 | 4 | 18 |
| 2022 10 | 1 | 2 | 3 |
| 2022 8 | 5 | 2 | 7 |
| 2022 5 | 2 | 2 | 4 |
| 2022 3 | 3 | 4 | 7 |
| 2021 1 | 2 | 0 | 2 |
| 2021 12 | 7 | 3 | 10 |
| 2021 11 | 16 | 2 | 18 |
| 2021 10 | 8 | 2 | 10 |
| 2021 9 | 1 | 0 | 1 |
| 2021 8 | 14 | 2 | 16 |
| 2021 7 | 1 | 2 | 3 |
| 2021 6 | 2 | 2 | 4 |
| 2021 5 | 8 | 4 | 12 |
| 2021 4 | 9 | 2 | 11 |
| 2021 3 | 4 | 2 | 6 |
| 2021 2 | 3 | 6 | 9 |
| 2020 1 | 1 | 2 | 3 |
| 2020 11 | 1 | 0 | 1 |
| 2020 10 | 1 | 2 | 3 |
| 2020 9 | 20 | 7 | 27 |
| 2020 8 | 1 | 2 | 3 |
| 2020 5 | 1 | 2 | 3 |
| 2020 4 | 13 | 4 | 17 |
| 2020 3 | 3 | 4 | 7 |
| 2020 2 | 1 | 2 | 3 |
| 2020 1 | 14 | 10 | 24 |
| 2019 12 | 1 | 2 | 3 |
| 2019 8 | 1 | 2 | 3 |
| 2019 5 | 1 | 0 | 1 |
| 2019 4 | 2 | 4 | 6 |
| 2019 3 | 3 | 4 | 7 |
| 2019 2 | 27 | 0 | 27 |
| 2019 1 | 4 | 4 | 8 |
| 2018 11 | 3 | 8 | 11 |
| 2018 10 | 5 | 6 | 11 |
| 2018 9 | 5 | 4 | 9 |
| 2018 8 | 1 | 1 | 2 |
| 2018 7 | 2 | 0 | 2 |
| 2018 6 | 0 | 1 | 1 |
| 2018 5 | 2 | 0 | 2 |
| 2018 4 | 2 | 2 | 4 |
| 2018 3 | 1 | 2 | 3 |
| 2018 2 | 7 | 2 | 9 |
| 2018 1 | 5 | 0 | 5 |
| 2017 11 | 2 | 0 | 2 |
| 2017 10 | 0 | 1 | 1 |
| 2017 9 | 2 | 1 | 3 |
| 2017 8 | 0 | 2 | 2 |
| 2017 7 | 5 | 0 | 5 |
| 2017 6 | 0 | 1 | 1 |
| 2017 5 | 6 | 3 | 9 |
| 2017 4 | 4 | 6 | 10 |
| 2017 3 | 24 | 4 | 28 |
| 2017 2 | 0 | 1 | 1 |
| 2016 1 | 0 | 3 | 3 |
| 2016 12 | 0 | 1 | 1 |
| 2016 11 | 0 | 2 | 2 |
Mostrar todo
